WEST VIRGINIA UNIVERSITY

Dr. Partho P. Sengupta, Chief of Cardiovascular Medicine at Rutgers RWJMS, was honored by AACIO for his research and inclusive care for South Asian and Indian communities. He emphasizes the need for diverse representation in clinical studies to address specific health care needs.

The Inflation Reduction Act's drug price negotiation program faces uncertainty under Trump's administration. The 'pill penalty' provision, which allows small molecule medicines to be eligible for selection nine years after FDA approval, four years before large molecule medicines, has sparked controversy. Critics argue this disparity could harm investment in small molecule drug development. Proposed bills like the EPIC Act aim to provide parity for the two drug classes, but budgetary concerns and arguments against extending small molecules' exclusivity period complicate the issue. The biopharma industry, including organizations like PhRMA and BIO, strongly opposes the 'pill penalty', fearing reduced R&D investment and fewer small molecule medicines developed.

A form includes a state dropdown with options for U.S. states, territories, and Canadian provinces, a zip code input field, and a country dropdown with numerous country options.

WVU and Marshall collaborate with GameChanger, prevention leaders, and local coalitions to launch 'One State, One Vision,' a comprehensive Prevention Education Plan aimed at addressing substance use in West Virginia schools and communities, supported by the West Virginia Department of Human Services and state Prevention Partners.

WVU Rockefeller Neuroscience Institute receives $2 million for first-in-the-world clinical research studies using focused ultrasound neuromodulation to treat food addiction, PTSD, and other conditions.

Governor Jim Justice announced $2 million for WVU Rockefeller Neuroscience Institute to expand research on food addiction, PTSD, and Alzheimer’s, and $1 million for Mylan Park’s KOA RV Resort Phase II, including 26 cabins and road paving.

Dr. Sally Hodder, WVU physician and researcher, elected to National Academy of Medicine for her work in infectious diseases, rural health, and HIV treatment, becoming the first from WVU to receive this honor.

West Virginia passed a bill allowing two medical research trials on opioid use disorder, comparing buprenorphine and methadone. The study, led by Yale and Pittsburgh universities, aims to improve treatment access and effectiveness, with potential implications for state laws and public perception of methadone.

MeiraGTx's gene therapy (AAV-GAD) for Parkinson’s disease passed midphase trial, showing significant improvement in PDQ-39 scores at 26 weeks with high-dose treatment, and is now in discussion for Phase III. AAV-GAD was safe and well-tolerated, with no SAEs related to treatment.